Haiyong Han

发表

Towards continuous-to-continuous 3D imaging in the real world

Luca Caucci, Harrison H Barrett, Abhinav K. Jha, 2019, Physics in medicine and biology.

Abstract A30: Integrated analysis of genomic data and annotations in cancer research

Seungchan Kim, Manuel Hidalgo, Haiyong Han, 2009 .

Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling

Matthew S. Creamer, William S. Hlavacek, Michael E. Berens, 2012, BMC Systems Biology.

SuperCT: A supervised-learning-framework to enhance the characterization of single-cell transcriptomic profiles

Peng Xie, Chaoyong Yang, Michael Q. Zhang, 2018 .

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Eric W. Klee, Stephen D. Mastrian, Ahmet Kurdoglu, 2014, PLoS genetics.

Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agents.

Spyro Mousses, Haiyong Han, S. Mousses, 2006, Seminars in oncology.

The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.

Haiyong Han, D. V. Von Hoff, R. Nagle, 2004, Molecular cancer therapeutics.

Erratum: Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray (Cancer Research (May 15, 2002) (2890-2896))

Raymond B. Nagle, Haiyong Han, Daniel D. Von Hoff, 2002 .

SuperCT: a supervised-learning framework for enhanced characterization of single-cell transcriptomic profiles

Michael Q. Zhang, Jianfei Zhang, Chaoyong Yang, 2019, Nucleic acids research.

Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.

Jeff Kiefer, Spyro Mousses, Haiyong Han, 2012, Biochemical pharmacology.

Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.

Haiyong Han, D. V. Von Hoff, R. Nagle, 2002, Cancer research.

Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer

Haiyong Han, Galen Hostetter, G. Hostetter, 2017, PloS one.

Hitting multiple targets with multimeric ligands

Robert J Gillies, Josef Vagner, Haiyong Han, 2004, Expert opinion on therapeutic targets.

Desmoplasia and chemoresistance in pancreatic cancer

Richard G. Posner, Haiyong Han, Daniel D. Von Hoff, 2012 .

Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis.

Michael Tiemeyer, Kazuhiro Aoki, Lance Wells, 2014, Journal of proteome research.

The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.

Haiyong Han, D. V. Von Hoff, D. Bearss, 2002, Molecular cancer therapeutics.

Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells

Haiyong Han, Phillip Stafford, Laurence H. Hurley, 2006, Molecular Cancer Therapeutics.

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer

Robert J Gillies, Haiyong Han, Galen Hostetter, 2008, Molecular Cancer Therapeutics.